Perpetual Ltd’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
RG
CDDEC
BTCPP
AAMU
AIM
AV
Perpetual Ltd's AZN Position: Q2 2026 in Review
Perpetual Ltd reduced its AstraZeneca (AZN) stake by 40% in Q2 2026, selling an estimated $150K and leaving 1,191 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #414.
Perpetual Ltd first reported a position in AZN in Q3 2020 and has held it in 15 quarters since. The position peaked at $3.96M in Q2 2024. 543 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Perpetual Ltd held 1,191 shares of AstraZeneca worth $226K as of Q2 2026.
- Perpetual Ltd sold 797 AstraZeneca shares in Q2 2026, an estimated $150K.
- AstraZeneca made up ﹤0.01% of Perpetual Ltd's portfolio in Q2 2026, its #414 holding.
- Perpetual Ltd first reported a position in AstraZeneca in Q3 2020 and has held it in 15 quarters since.
- Perpetual Ltd's AstraZeneca position peaked at $3.96M in Q2 2024.
- 543 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Perpetual Ltd's 13F filing for Q2 2026, filed 15 Jul 2026.